Novartis Institute for Tropical Diseases (NITD)
A small-molecule drug discovery research institute working on new treatments and prevention methods for dengue, tuberculosis and malaria.
The Novartis Institute for Tropical Diseases aims to discover novel treatments and prevention methods for major tropical diseases and contributes to education by its teaching and training opportunities.
Lively community of more than 100 international scientists located in Singapore with 30 collaborators around the globe.
NEHCRI is a joint research initiative that lays the groundwork for the clinical development of new medicines against tropical diseases.
Master’s degree infectious diseases ›
NITD has teamed up with University of Basel, Swiss Tropical Institute and National University of Singapore to create a joint Master of Science program in infectious diseases, vaccinology and drug discovery.
Research & Development at NITD ›
Drug-discovery expertise and cutting-edge technology of Novartis to fight infectious tropical diseases: dengue, tuberculosis and malaria.
NITD has a strong network of scientific partnerships and collaborations in Singapore and around the world. NITD is constantly seeking new collaboration opportunities.
List of publications resulted from the work we do.
Corporate Citizenship
Corporate citizenship at Novartis is an integral part of how we operate and a key to our success.
Collaborations map
Neglected diseases
We aim to discover new treatments and prevention methods for major tropical diseases. Learn more about the main tropical diseases: